BioInvent International AB (publ) ( BOVNF) - Stock Earnings

BOVNF Upcoming earnings

Estimated EPS and revenue columns are available to paid members.

Date EPS (actual / est.) Revenue low (est.) Revenue (actual / est.) Revenue high (est.)
Oct. 29, 2026, midnight — / — — — / — —

BOVNF Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q4 -13.7 million USD 326738 USD
2026Q1 -12.5 million USD 1.4 million USD
2026Q2 -12.5 million USD 1.3 million USD
2026Q4 Est. — —

BOVNF Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -32.8 million USD 7.1 million USD
2024 -39.0 million USD 4.1 million USD
2025 -36.1 million USD 24.5 million USD
2026 Est. — —

BOVNF

Price: $3.29

52 week price:
3.29
4.70

Earnings Per Share: -0.47 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 216.4 million

Links: